Rowe H.M., Huntley J.F. From the outside-in: The Francisella tularensis envelope and virulence. Front. Cell Infect. Microbiol. 2015; 5:94. DOI: 10.3389/fcimb.2015.00094..
DOI: 10.3389/fcimb.2015.00094

Подладчикова О.Н. Современные представления о молекулярных механизмах патогенеза чумы. Проблемы особо опасных инфекций. 2017; 3:33–40. DOI: 10.21055/0370-1069-2017-3-33-40..
DOI: 10.21055/0370-1069-2017-3-33-40

Livorsi D.J., Stenehjem E., Stephens D.S. Virulence factors of gram-negative bacteria in sepsis with a focus on Neisseria meningitidis. Contrib. Microbiol. 2011; 17:31–47. DOI: 10.1159/000324008..
DOI: 10.1159/000324008

Knox K.W., Vesk M., Work E. Relation between excreted lipopolysaccharide complexes and surface structures of a lysinelimited culture of Escherichia coli. J. Bacteriol. 1966; 92(4): 1206–17. DOI: 10.1128/JB.92.4.1206-1217.1966..
DOI: 10.1128/JB.92.4.1206-1217.1966

Chatterjee S.N., Das J. Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. J. Gen. Microbiol. 1967; 49(1):1–11. DOI: 10.1099/00221287-49-1-1..
DOI: 10.1099/00221287-49-1-1

Beveridge T.J. Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 1999; 181(16):4725–33. DOI: 10.1128/JB.181.16.4725-4733.1999..
DOI: 10.1128/JB.181.16.4725-4733.1999

Ellis T.N., Kuehn M.J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 2010; 74(1):81–94. DOI: 10.1128/MMBR.00031-09..
DOI: 10.1128/MMBR.00031-09

Yoon H. Bacterial outer membrane vesicles as a delivery system for virulence regulation. J. Microbiol. Biotechnol. 2016; 26(8):1343–7. DOI: 10.4014/jmb.1604.04080..
DOI: 10.4014/jmb.1604.04080

Луста К.А., Кондашевская М.В. Участие внеклеточных мембранных нановезикул бактерий в патологических процессах. Вестник новых медицинских технологий. Электронное издание. 2019; 2. Публикация 3–5. [Электронный ресурс]. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2019-2/3-5.pdf (дата обращения 03.04.2019). DOI: 10.24411/2075-4094-2019-16306..
DOI: 10.24411/2075-4094-2019-16306http://www.medtsu.tula.ru/VNMT/Bulletin/E2019-2/3-5.pdf

Луста К.А., Кондашевская М.В. Участие внеклеточных мембранных нановезикул бактерий в патологических процессах. Вестник новых медицинских технологий. Электронное издание. 2019; 2. Публикация 3–5. [Электронный ресурс]. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2019-2/3-5.pdf (дата обращения 03.04.2019). DOI: 10.24411/2075-4094-2019-16306..
DOI: 10.24411/2075-4094-2019-16306http://www.medtsu.tula.ru/VNMT/Bulletin/E2019-2/3-5.pdf

Шендеров Б.А., Синица А.В., Захарченко М.М., Ткаченко Е.И. Внеклеточные везикулы (экзосомы) и их роль в биологии бактерий и реализации их патогенного потенциала. Экспериментальная и клиническая гастроэнтерология. 2020; 7:118–30. DOI: 10.31146/1682-8658-ecg-179-7-118-130..
DOI: 10.31146/1682-8658-ecg-179-7-118-130

Kulp A., Kuehn M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 2010; 64:163–84. DOI: 10.1146/annurev.micro.091208.073413..
DOI: 10.1146/annurev.micro.091208.073413

Tran F., Boedicker J.Q. Genetic cargo and bacterial species set the rate of vesicle-mediated horizontal gene transfer. Sci. Rep. 2017; 7(1):8813. DOI: 10.1038/s41598-017-07447-7..
DOI: 10.1038/s41598-017-07447-7

Kuehn M.J., Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes. Dev. 2005; 19(22):2645–55. DOI: 10.1101/gad.1299905..
DOI: 10.1101/gad.1299905

Rueter C., Bielaszewska M. Secretion and delivery of intestinal pathogenic Escherichia coli virulence factors via outer membrane vesicles. Front. Cell Infect. Microbiol. 2020; 10:91. DOI: 10.3389/fcimb.2020.00091..
DOI: 10.3389/fcimb.2020.00091

Lai C.H., Listgarten M.A., Hammond B.F. Comparative ultrastructure of leukotoxic and non-leukotoxic strains of Actinobacillus actinomycetemcomitans. J. Periodontal. Res. 1981; 16(4):379–89. DOI: 10.1111/j.1600-0765.1981.tb00989.x..
DOI: 10.1111/j.1600-0765.1981.tb00989.x

Wang S., Gao J., Wang Z. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2019; 11(2):e1523. DOI: 10.1002/wnan.1523..
DOI: 10.1002/wnan.1523

Pizza M., Bekkat-Berkani R., Rappuoli R. Vaccines against meningococcal diseases. Microorganisms. 2020; 8(10):1521. DOI: 10.3390/microorganisms8101521..
DOI: 10.3390/microorganisms8101521

Elluri S., Enow C., Vdovikova S., Rompikuntal P.K., Dongre M., Carlsson S., Pal A., Uhlin B.E., Wai S.N. Outer membrane vesicles mediate transport of biologically active Vibrio cholerae cytolysin (VCC) from V. cholerae strains. PLoS One. 2014; 9(9):e106731. DOI: 10.1371/journal.pone.0106731..
DOI: 10.1371/journal.pone.0106731

Rasti E.S., Schappert M.L., Brown A.C. Association of Vibrio cholerae 569B outer membrane vesicles with host cells occurs in a GM1-independent manner. Cell Microbiol. 2018; 20(6):e12828. DOI: 10.1111/cmi.12828..
DOI: 10.1111/cmi.12828

Rasti E.S., Brown A.C. Cholera toxin encapsulated within several Vibrio cholerae O1 serotype Inaba outer membrane vesicles lacks a functional B-subunit. Toxins (Basel). 2019; 11(4):207. DOI: 10.3390/toxins11040207..
DOI: 10.3390/toxins11040207

Rompikuntal P.K., Vdovikova S., Duperthuy M., Johnson T.L., Åhlund M., Lundmark R., Oscarsson J., Sandkvist M., Uhlin B.E., Wai S.N. Outer membrane vesicle-mediated export of processed PrtV protease from Vibrio cholerae. PLoS One. 2015; 10(7):e0134098. DOI: 10.1371/journal.pone.0134098..
DOI: 10.1371/journal.pone.0134098

Mondal A., Tapader R., Chatterjee N.S., Ghosh A., Sinha R., Koley H., Saha D.R., Chakrabarti M.K., Wai S.N., Pal A. Cytotoxic and inflammatory responses induced by outer membrane vesicleassociated biologically active proteases from Vibrio cholerae. Infect. Immun. 2016; 84(5):1478–90. DOI: 10.1128/IAI.01365-15..
DOI: 10.1128/IAI.01365-15

Bitar A., Aung K.M., Wai S.N., Hammarström M.-L. Vibrio cholerae derived outer membrane vesicles modulate the inflammatory response of human intestinal epithelial cells by inducing microRNA-146a. Sci. Rep. 2019; 9(1):7212. DOI: 10.1038/s41598-019-43691-9..
DOI: 10.1038/s41598-019-43691-9

Altindis E., Fu Y., Mekalanos J.J. Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc. Natl Acad. Sci. USA. 2014; 111(15):E1548–56. DOI: 10.1073/pnas.1403683111..
DOI: 10.1073/pnas.1403683111

Sjöström A.E., Sandblad L., Uhlin B.E., Wai S.N. Membrane vesicle-mediated release of bacterial RNA. Sci. Rep. 2015; 5:15329. DOI: 10.1038/srep15329..
DOI: 10.1038/srep15329

Song T., Mika F., Lindmark B., Liu Z., Schild S., Bishop A., Zhu J., Camilli A., Johansson J., Vogel J., Wai S.N. A new Vibrio cholerae RNA modulates colonization and affects release of outer membrane vesicles. Mol. Microbiol. 2008; 70(1):100–11. DOI: 10.1111/j.1365-2958.2008.06392.x..
DOI: 10.1111/j.1365-2958.2008.06392.x

Zingl F.G., Kohl P., Cakar F., Leitner D.R., Mitterer F., Bonnington K.E., Rechberger G.N., Kuehn M.J., Guan Z., Reidl J., Schild S. Outer membrane vesiculation facilitates surface exchange and in vivo adaptation of Vibrio cholerae. Cell Host Microbe. 2020; 27(2):225–37.e8. DOI: 10.1016/j.chom.2019.12.002..
DOI: 10.1016/j.chom.2019.12.002

Fong J.N.C., Yildiz F.H. Biofilm matrix proteins. Microbiol. Spectr. 2015; 3(2). DOI: 10.1128/microbiolspec.MB-0004-2014..
DOI: 10.1128/microbiolspec.MB-0004-2014

Abd H., Saeed A., Weintraub A., Nair G.B., Sandström G. Vibrio cholerae O1 strains are facultative intracellular bacteria, able to survive and multiply symbiotically inside the aquatic free-living amoeba Acanthamoeba castellanii. FEMS Microbiol. Ecol. 2007; 60(1):33–9. DOI: 10.1111/j.1574-6941.2006.00254.x..
DOI: 10.1111/j.1574-6941.2006.00254.x

Valeru S.P., Shanan S., Alossimi H., Saeed A., Sandström G., Abd H. Lack of outer membrane protein a enhances the release of outer membrane vesicles and survival of Vibrio cholerae and suppresses viability of Acanthamoeba castellanii. Int. J. Microbiol. 2014; 2014:610190. DOI: 10.1155/2014/610190..
DOI: 10.1155/2014/610190

Reyes-Robles T., Dillard R.S., Cairns L.S., Silva-Valenzuela C.A., Housman M., Ali A., Wright E.R., Camilli A. Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. J. Bacteriol. 2018; 200(15):e00792-17. DOI: 10.1128/JB.00792-17..
DOI: 10.1128/JB.00792-17

Adriani R., Mousavi Gargari S.L., Nazarian S., Sarvary S., Noroozi N. Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions. Vaccine. 2018; 36(2):322–30. DOI: 10.1016/j.vaccine.2017.09.004..
DOI: 10.1016/j.vaccine.2017.09.004

Sedaghat M., Siadat S.D., Mirabzadeh E., Keramati M., Vaziri F., Shafiei M., Shahcheraghi F. Evaluation of antibody responses to outer membrane vesicles (OMVs) and killed whole cell of Vibrio cholerae O1 El Tor in immunized mice. Iran J. Microbiol. 2019; 11(3):212–9.

Wang Z., Lazinski D.W., Camilli A. Immunity provided by an outer membrane vesicle cholera vaccine is due to О-antigenspecific antibodies inhibiting bacterial motility. Infect. Immun. 2016; 85(1):e00626–16. DOI: 10.1128/IAI.00626-16..
DOI: 10.1128/IAI.00626-16

Sinha R., Howlader D.R., Ta A., Mitra S., Das S., Koley H. Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity. Vaccine. 2017; 35(28):3534–47. DOI: 10.1016/j.vaccine.2017.05.036..
DOI: 10.1016/j.vaccine.2017.05.036

Kolodziejek A.M., Caplan A.B., Bohach G.A., Paszczynski A.J., Minnich S.A., Hovde C.J. Physiological levels of glucose induce membrane vesicle secretion and affect the lipid and рrotein composition of Yersinia pestis cell surfaces. Appl. Environ. Microbiol. 2013; 79(14):4509–14. DOI: 10.1128/AEM.00675-13..
DOI: 10.1128/AEM.00675-13

Eddy J.L., Gielda L.M., Caulfield A.J., Rangel S.M., Lathem W.W. Production of outer membrane vesicles by the plague pathogen Yersinia pestis. PLoS One. 2014; 9(9):e107002. DOI: 10.1371/journal.pone.0107002..
DOI: 10.1371/journal.pone.0107002

Дудина Л.Г., Малкова М.А., Чернядьев А.В., Литвинец C.Г., Бывалов А.А. Влияние специфических бактериофагов и гентамицина на морфологию и везикулообразование бактерий Yersinia pestis EV. Проблемы особо опасных инфекций. 2019; 2:50–4. DOI: 10.21055/0370-1069-2019-2-50-54..
DOI: 10.21055/0370-1069-2019-2-50-54

Carvalho A.L., Miquel-Clopés A., Wegmann U., Jones E., Stentz R., Telatin A., Walker N.J., Butcher W.A., Brown P.J., Holmes S., Dennis M.J., Williamson E.D., Funnell S.G.P., Stock M., Carding S.R. Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization. Clin. Exp. Immunol. 2019; 196(3):287–304. DOI: 10.1111/cei.13301..
DOI: 10.1111/cei.13301

Wang X., Singh A.K., Zhang X., Sun W. Induction of protective antiplague immune responses by self-adjuvanting bionanoparticles derived from engineered Yersinia pestis. Infect Immun. 2020; 88(5):e00081-20. DOI: 10.1128/IAI.00081-20..
DOI: 10.1128/IAI.00081-20

Олсуфьев Н.Г., Руднев Г.П., редакторы. Туляремия. М.: Медгиз; 1960. 460 с.

Pierson T., Matrakas D., Taylor Y.U., Manyam G., Morozov V.N., Zhou W., van Hoek M.L. Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine. J. Proteome Res. 2011; 10(3):954–67. DOI: 10.1021/pr1009756..
DOI: 10.1021/pr1009756

McCaig W.D., Koller А., Thanassi D.G. Production of outer membrane vesicles and outer membrane tubes by Francisella novicida. J. Bacteriol. 2013; 195(6):1120–32. DOI: 10.1128/JB.02007-12..
DOI: 10.1128/JB.02007-12

Champion A.E., Bandara A.B., Mohapatra N., Fulton K.M., Twine S.M., Inzana T.J. Further characterization of the capsule- like complex (CLC) produced by Francisella tularensis subspecies tularensis: protective efficacy and similarity to outer membrane vesicles. Front. Cell Infect. Microbiol. 2018; 8:182. DOI: 10.3389/fcimb.2018.00182..
DOI: 10.3389/fcimb.2018.00182

Sampath V., McCaig W.D., Thanassi D.G. Amino acid deprivation and central carbon metabolism regulate the production of outer membrane vesicles and tubes by Francisella. Mol. Microbiol. 2018; 107(4):523–41. DOI: 10.1111/mmi.13897..
DOI: 10.1111/mmi.13897

Siebert C., Lindgren H., Ferré S., Villers C., Boisset S., Perard J., Sjöstedt A., Maurin M., Brochier-Armanet C., Couté Y., Renesto P. Francisella tularensis: FupA mutation contributes to fluoroquinolone resistance by increasing vesicle secretion and biofilm formation. Emerg. Microbes Infect. 2019; 8(1):808–22. DOI: 10.1080/22221751.2019.1615848..
DOI: 10.1080/22221751.2019.1615848

Chen F., Cui G., Wang S., Nair M.K. M., He L., Qi X., Han X., Zhang H., Zhang J.-R., Su J. Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS. Emerg. Microbes Infect. 2017; 6(7):с66. DOI: 10.1038/emi.2017.53..
DOI: 10.1038/emi.2017.53

Klimentova J., Pavkova I., Horcickova L., Bavlovic J., Kofronova O., Benada O., Stulik J. Francisella tularensis subsp. Holarctica releases differentially loaded outer membrane vesicles under various stress conditions. Front. Microbiol. 2019; 10:2304. DOI: 10.3389/fmicb.2019.02304..
DOI: 10.3389/fmicb.2019.02304

Chen L., Valentine J.L., Huang C.J., Endicott C.E., Moeller T.D., Rasmussen J.A., Fletcher J.R., Boll J.M., Rosenthal J.A., Dobruchowska J., Wang Z., Heiss C., Azadi P., Putnam D., Trent M.S., Jones B.D., DeLisa M.P. Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies. Proc. Natl Acad. Sci. USA. 2016; 113(26):E3609-18. DOI: 10.1073/pnas.1518311113..
DOI: 10.1073/pnas.1518311113

Gamazo C., Moriyon I. Release of outer membrane fragments by exponentially growing Brucella melitensis cells. Infect. Immun. 1987; 55(3):609–15. DOI: 10.1128/IAI.55.3.609-615.1987..
DOI: 10.1128/IAI.55.3.609-615.1987

Pollak C.N., Delpino M.V., Fossati C.A., Baldi P.C. Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response. PLoS One. 2012; 7(11):e50214. DOI: 10.1371/journal.pone.0050214..
DOI: 10.1371/journal.pone.0050214

Zavattieri L., Ferrero M.C., Alonso Paiva I.M., Sotelo A.D., Canellada A.M., Baldi P.C. Brucella abortus proliferates in decidualized and non-decidualized human endometrial cells inducing a proinflammatory response. Pathogens. 2020; 9(5):369. DOI: 10.3390/pathogens9050369..
DOI: 10.3390/pathogens9050369

Avila-Calderón E.D., Lopez-Merino A., Jain N., Peralta H., López-Villegas E.O., Sriranganathan N., Boyle S.M., Witonsky S., Contreras-Rodríguez A. Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice. Clin. Dev. Immunol. 2012; 2012:352493. DOI: 10.1155/2012/352493..
DOI: 10.1155/2012/352493

Avila-Calderón E.D., Medina-Chávez O., Flores-Romo L., Hernández-Hernández J.M., Donis-Maturano L., López-Merino A., Arellano-Reynoso B., Aguilera-Arreola M.G., Ruiz E.A., Gomez-Lunar Z., Witonsky S., Contreras-Rodríguez A. Outer membrane vesicles from Brucella melitensis modulate immune response and induce cytoskeleton rearrangement in peripheral blood mononuclear cells. Front Microbiol. 2020; 11:556795. DOI: 10.3389/fmicb.2020.556795..
DOI: 10.3389/fmicb.2020.556795

Kaur G., Singh S., Sunil Kumar B.V., Mahajan K., Verma R. Сharacterization and immunogenicity of outer membrane vesicles.
DOI: 10.1080/15321819.2015.1132231

from Brucella abortus. J. Immunoassay Immunochem. 2016; 37(3):261–72. DOI: 10.1080/15321819.2015.1132231..
DOI: 10.1080/15321819.2015.1132231

from Brucella abortus. J. Immunoassay Immunochem. 2016; 37(3):261–72. DOI: 10.1080/15321819.2015.1132231..
DOI: 10.1111/apm.12997

Bagheri Nejad R., Yahyaraeyat R., Es-Haghi A., Nayeri Fasayi B., Zahraei Salehi T. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate. APMIS. 2019; 127(12):797–804. DOI: 10.1111/apm.12997..
DOI: 10.1111/apm.12997

Bagheri Nejad R., Yahyaraeyat R., Es-Haghi A., Nayeri Fasayi B., Zahraei Salehi T. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate. APMIS. 2019; 127(12):797–804. DOI: 10.1111/apm.12997..
DOI: 10.1016/j.intimp.2020.106573

Golshani M., Amani M., Amirzadeh F., Nazeri E., Davar Siadat S., Nejati-Moheimani M., Arsang A., Bouzari S. Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice. Int. Immunopharmacol. 2020; 84:106573. DOI: 10.1016/j.intimp.2020.106573..
DOI: 10.1016/j.intimp.2020.106573

Golshani M., Amani M., Amirzadeh F., Nazeri E., Davar Siadat S., Nejati-Moheimani M., Arsang A., Bouzari S. Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice. Int. Immunopharmacol. 2020; 84:106573. DOI: 10.1016/j.intimp.2020.106573..
DOI: 10.1371/journal.pone.0014361

Nieves W., Heang J., Asakrah S., Höner zu Bentrup K., Roy C.J., Morici L.A. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS One. 2010; 5(12):e14361. DOI: 10.1371/journal.pone.0014361..
DOI: 10.1371/journal.pone.0014361

Nieves W., Heang J., Asakrah S., Höner zu Bentrup K., Roy C.J., Morici L.A. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS One. 2010; 5(12):e14361. DOI: 10.1371/journal.pone.0014361..
DOI: 10.1016/j.vaccine.2011.08.058

Nieves W., Asakrah S., Qazi O., Brown K.A., Kurtz J., Aucoin D.P., McLachlan J.B., Roy C.J., Morici L.A. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine. 2011; 29(46):8381–9. DOI: 10.1016/j.vaccine.2011.08.058..
DOI: 10.1016/j.vaccine.2011.08.058

Nieves W., Asakrah S., Qazi O., Brown K.A., Kurtz J., Aucoin D.P., McLachlan J.B., Roy C.J., Morici L.A. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine. 2011; 29(46):8381–9. DOI: 10.1016/j.vaccine.2011.08.058..
DOI: 10.1128/CVI.00119-14

Nieves W., Petersen H., Judy B.M., Blumentritt C.A., Russell-Lodrigue K., Roy C.J., Torres A.G., Morici L.A. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin. Vaccine Immunol. 2014; 21(5):747–54. DOI: 10.1128/CVI.00119-14..
DOI: 10.1128/CVI.00119-14

Nieves W., Petersen H., Judy B.M., Blumentritt C.A., Russell-Lodrigue K., Roy C.J., Torres A.G., Morici L.A. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin. Vaccine Immunol. 2014; 21(5):747–54. DOI: 10.1128/CVI.00119-14..
DOI: 10.1016/j.provac.2014.07.007

Petersen H., Nieves W., Russell-Lodrigue K., Roy C.J., Morici L.A. Evaluation of a Burkholderia pseudomallei outer membrane vesicle vaccine in nonhuman primates. Procedia Vaccinol. 2014; 8:38–42. DOI: 10.1016/j.provac.2014.07.007..
DOI: 10.1016/j.provac.2014.07.007

Petersen H., Nieves W., Russell-Lodrigue K., Roy C.J., Morici L.A. Evaluation of a Burkholderia pseudomallei outer membrane vesicle vaccine in nonhuman primates. Procedia Vaccinol. 2014; 8:38–42. DOI: 10.1016/j.provac.2014.07.007..
DOI: 10.3390/vaccines5040049

Baker S.M., Davitt C.J.H., Motyka N., Kikendall N.L., Russell-Lodrigue K., Roy C.J., Morici L.A. A Burkholderia pseudomallei outer membrane vesicle vaccine provides cross protection against inhalational glanders in mice and non-human primates. Vaccines (Basel). 2017; 5(4):49. DOI: 10.3390/vaccines5040049..
DOI: 10.3390/vaccines5040049

Baker S.M., Davitt C.J.H., Motyka N., Kikendall N.L., Russell-Lodrigue K., Roy C.J., Morici L.A. A Burkholderia pseudomallei outer membrane vesicle vaccine provides cross protection against inhalational glanders in mice and non-human primates. Vaccines (Basel). 2017; 5(4):49. DOI: 10.3390/vaccines5040049..
DOI: 10.3390/vaccines6010005

Norris M.H., Khan M.S.R., Chirakul S., Schweizer H.P., Tuanyok A. Outer membrane vesicle vaccines from biosafe surrogates prevent acute lethal glanders in mice. Vaccines (Basel). 2018; 6(1):5. DOI: 10.3390/vaccines6010005..
DOI: 10.3390/vaccines6010005

Norris M.H., Khan M.S.R., Chirakul S., Schweizer H.P., Tuanyok A. Outer membrane vesicle vaccines from biosafe surrogates prevent acute lethal glanders in mice. Vaccines (Basel). 2018; 6(1):5. DOI: 10.3390/vaccines6010005..
DOI: 10.1073/pnas.1008843107

Rivera J., Cordero R.J., Nakouzi A.S., Frases S., Nicola A., Casadevall A. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl Acad. Sci. USA. 2010; 107(44):19002–7. DOI: 10.1073/pnas.1008843107..
DOI: 10.1073/pnas.1008843107